Prestige Consumer Healthcare
Stock Forecast, Prediction & Price Target
Prestige Consumer Healthcare (PBH) stock Price Target by analysts
$86
Potential upside: 28.91%
Prestige Consumer Healthcare price prediction
What is Prestige Consumer Healthcare stock analysts` prediction?
Prestige Consumer Healthcare stock forecast: Based on 1 Wall Street analysts` predicted price targets for Prestige Consumer Healthcare in the last 3 months, the avarage price target is $86, with a high forecast of $NaN. The average price target represents a 28.91% change from the last price of $66.71.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Prestige Consumer Healthcare stock Price Target by analysts
Full breakdown of analysts given Prestige Consumer Healthcare price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Susan Anderson Canaccord Genuity | 0% 0/1 | 11 months ago | $86 28.91% upside | $74.58 | StreetInsider | Previous targets (0) |
Linda Bolton Weiser D.A. Davidson | 0% 0/1 | over 1 year ago | $93 39.40% upside | $68.13 | StreetInsider | Previous targets (0) |
Unknown Canaccord Genuity | N/A | almost 3 years ago | $71 6.43% upside | $58.35 | Benzinga | N/A |
Prestige Consumer Healthcare Financial Estimates
Prestige Consumer Healthcare Revenue Estimates
Prestige Consumer Healthcare EBITDA Estimates
Prestige Consumer Healthcare Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 3/31/2022 | 3/31/2023 | 3/31/2024 | 3/31/2026 | 3/31/2027 | ||
Revenue
% change YoY
| $1.08B N/A | $1.12B 3.76% | $1.12B -0.20% | Avg: $1.15B Low: $1.15B High: $1.16B avg. 2.80% | Avg: $1.18B Low: $1.18B High: $1.19B avg. 2.42% | ||
Net Income
% change YoY
| $205.38M N/A | $-82.30M -140.07% | $209.33M 354.34% | Avg: $234.55M Low: $230.81M High: $240.85M avg. 12.04% | Avg: $236M Low: $238.99M High: $241.20M avg. 0.61% | ||
EBITDA
% change YoY
| $360.95M N/A | $14.18M -96.07% | $373.86M 2535.60% | Avg: $388.42M Low: $387.36M High: $391.80M avg. 3.89% | Avg: $397.85M Low: $396.77M High: $399.59M avg. 2.42% | ||
EPS
% change YoY
| $4.09 N/A | -$1.65 -140.34% | $4.21 355.15% | Avg: $4.7 Low: $4.6 High: $4.8 avg. 11.55% | Avg: $4.78 Low: $4.76 High: $4.81 avg. 1.77% | ||
Operating Expenses
% change YoY
| $290.72M N/A | $277.49M -4.55% | $282.01M 1.63% | Avg: $273.97M Low: $273.22M High: $276.35M avg. -2.85% | Avg: $280.63M Low: $279.86M High: $281.85M avg. 2.42% | ||
FAQ
What is Prestige Consumer Healthcare stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 6.33% in 2026-2027.
We have gathered data from 5 analysts. Their low estimate is 230.81M, average is 234.55M and high is 240.85M.
What is Prestige Consumer Healthcare stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 2.61% in 2026-2027.
We have gathered data from 5 analysts. Their low revenue estimate is $1.15B, average is $1.15B and high is $1.16B.
What is Prestige Consumer Healthcare stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 6.66% in 2026-2027.
We have gathered data from 5 analysts. Their low earnings per share estimate is $4.6, average is $4.7 and high is $4.8.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering Prestige Consumer Healthcare stock. The most successful analyst is Susan Anderson.